3P BIOTECH NORWAY AS: årsregnskap 2024 vs 2023
Another loss-making year
approved 2025-04-22; registry 2025-05-03; journal 2025 402130
Summary
What changed
Comparing Årsregnskap 2024 with 2023 for 3P BIOTECH NORWAY AS. Net result -49.1k NOK → -53.1k NOK. Equity 258.8k NOK → 205.7k NOK.
On the constructive side: cash rose. Pressures included: operating result weakened; net result weakened; equity eroded.
Net tougher year on the published lines.
At a glance
Scorecard
Revenue
1 121 NOK
n/m
—
Operating result
-48.4k NOK
-68.0k NOK
-40.5%
Net result
-49.1k NOK
-53.1k NOK
-8.1%
Equity
258.8k NOK
205.7k NOK
-20.5%
Cash
-283.1k NOK
449 NOK
+100.2%
What improved
-
↑
Cash rose
Bank deposits -283.1k NOK → 449 NOK (+100.2% YoY). Calculated
What deteriorated
-
↓
Operating result weakened
Operating result -48.4k NOK → -68.0k NOK. Calculated
-
↓
Net result weakened
Net result -49.1k NOK → -53.1k NOK. Calculated
-
↓
Equity eroded
Book equity 258.8k NOK → 205.7k NOK. Calculated